Friday, 16 October 2026European Markets

APERAM And ERAMET Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - aperam (apam.as) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
aperam (apam.as) €32.82 5.95% 19.73%
eramet (era.pa) €86.80 3.94% 51.96%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. aperam (apam.as)

5.95% forward dividend yield and 19.73% return on equity

aperam s.a., together with its subsidiaries, engages in the production and sale of stainless and specialty steel products worldwide. it operates through four segments: stainless & electrical steel; services & solutions; alloys & specialties; and recycling & renewables. the company offers range of stainless steel products, including grain oriented and non-grain oriented electrical steel products, and specialty alloys. it is also involved in the distribution of its products; and the provision of transformation services that include value added and customized steel solutions. in addition, the company designs, produces, and transforms various specialty alloys and other specific stainless steels in forms, such as bars, semis, cold-rolled strips, wire and wire rods, and plates in a range on grades. further, it engages in the trading, processing, and recycling of raw materials, such as superalloys and titanium; provides recyco, an electric arc furnace recycling facility that retrieves dust and sludge to recycle stainless steel raw materials and reduce waste; and produces wood and charcoal from cultivated eucalyptus forests. the company serves customers in aerospace, automotive, catering, construction, household appliances, electrical engineering, industrial processes, medical, and oil and gas industries. it distributes its products through a network of steel service centers, transformation facilities, and sales offices. the company was incorporated in 2010 and is headquartered in luxembourg city, luxembourg.

earnings per share

as for profitability, aperam has a trailing twelve months eps of €8.29.

pe ratio

aperam has a trailing twelve months price to earnings ratio of 3.96. meaning, the purchaser of the share is investing €3.96 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.73%.

revenue growth

year-on-year quarterly revenue growth grew by 15.8%, now sitting on 8.16b for the twelve trailing months.

more news about aperam.

2. eramet (era.pa)

3.94% forward dividend yield and 51.96% return on equity

eramet s.a. operates as a mining and metallurgical company in france, asia, europe, north america, and internationally. the company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. it also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. in addition, it operates moanda mine in gabon; nickel mines in new caledonia and indonesia; and mineral sand mine in senegal and argentina. eramet s.a. was incorporated in 1880 and is headquartered in paris, france.

earnings per share

as for profitability, eramet has a trailing twelve months eps of €30.53.

pe ratio

eramet has a trailing twelve months price to earnings ratio of 2.84. meaning, the purchaser of the share is investing €2.84 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.96%.

more news about eramet.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com